Record Date

To To Date: August 27, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Ring, Exchange Plaza, 5th Floor, Plot No. C/2, G Block, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Bandra (E), Dalal Street, Mumbai-400051 Mumbai – 400001 Symbol: BALPHARMA Scrip Code: 524824 Sub: Intimation of Record date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In continuation of our previous communication and pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, please be informed that the Record Date for payment of final dividend is fixed as follows: Security Code/ Type of security & Record Date Purpose Symbol paid-up value NSE : BALPHARMA Equity Shares of T h u r s d ay , F o r d e t e r m i n i n g the list of equity Rs. 10/- each 17th September, shareholders in the Register of BSE : 524824 2026 Members of the Company and the beneficial owners in the records of ISIN : INE083D01012 the Depositories as on the Record Date who will be entitled to the final dividend declared for FY 2025- Rate of Dividend : Rs. 1.20 (Rupees One and Twenty Paise only) per Equity Share of Rs. 10/- each (i.e., 12% on the face value of the Equity Shares) Please takes this intimation on your records Thanking You. For Bal Pharma Limited Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681 Enclosure: Intimation to Shareholders regarding Dividend Payment Intimation to Shareholders regarding Dividend Payment Final dividend of Rs.1.20/- per share (after its approval at the AGM) will be paid on or after September 24, 2026 to the members holding equity shares of the Company as on record date i.e. September 17, 2026. Dividend income is taxable in the hands of the members and the Company is required to deduct tax at source ("TDS") from dividend paid to the members at prescribed rates in the Income Tax Act, 2025. In general, no tax will be deducted on payment of dividend to category of members who are resident individuals (with valid PAN details updated in their folio/client ID records) and the total dividend amount payable to them does not exceed Rs 10,000/-. Members falling under various categories and eligible to avail of Nil or lower rate of tax deduction at source (“TDS”) on dividend are requested to submit the requisite forms, declarations and supporting documents, as applicable to their category, through the designated online facility of the Registrar and Transfer Agent, MUFG Intime India Private Limited, at: https://web.in.mpms.mufg.com/formsreg/submission-of-Form-121-41.html Shareholders can send the other documents at the following email id: Resident Shareholders Csgexemptforms2627@in.mpms.mufg.com Non-Resident Shareholders investors@balpharma.com Members are advised to carefully review the applicable requirements and ensure that the requisite forms, declarations and supporting documents are submitted within the prescribed timelines to enable the Company/RTA to consider the same for deduction of tax at the applicable Nil or lower rate. Updation of bank account details: Shareholders are requested to ensure that their bank account details in their respective demat accounts/physical folios are updated, to enable the Company to effect timely credit of dividend in their bank accounts. We seek your cooperation in this regard. This Communication is not exhaustive and does not purport to be complete analysis or listing of all potential tax consequences in the matter of dividend payment. Shareholders should consult their tax advisors for requisite action to be taken by them. No claim shall lie against the Company for such taxes deducted. Post payment of the said Dividend, shareholders will also be able to see the credit of TDS in Form 168, which can be downloaded from their e-filing account at income tax department’s website https://eportal.incometax.gov.in/. The aforesaid information has also been duly communicated to the shareholders of the Company through e- mail. You are requested to kindly take the above information also on record.